MISSISSAUGA, ON, Aug. 5, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its Q2 2022 financial results on Thursday, August 11, 2022 after market close. The Company will also host a conference call on Friday, August 12, 2022 at 8:30am ET to discuss the results and corporate developments.
CONFERENCE CALL DETAILS
|
DATE:
|
August 12, 2022
|
|
|
|
TIME:
|
8:30 a.m. ET
|
|
|
|
DIAL-IN NUMBER:
|
(647) 484-0475 or (888) 220-8451
|
|
|
|
CONFERENCE ID:
|
7538758
|
|
|
|
REPLAY DIAL-IN:
|
(888) 203-1112 (playback 7538758#)
|
|
Expires August 19, 2022
|
|
|
|
WEBCAST:
|
https://app.webinar.net/871ZpObNzYX
|
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
View original content: http://www.newswire.ca/en/releases/archive/August2022/05/c3281.html